![]() |
![]() * FusionBase aims to serve as the base camp for understanding DNA breakage and coded structural variants, annotating the potential function of fusion genes/proteins, developing therapeutics targeting human fusion genes/proteins, clinical assessment of fusion genes/proteins, and distributing knowledge of fusion genes/proteins in diverse aspects including biology, biochemistry, pharmacology, and biomedical information. From the DNA breakpoint information, until we identify fusion-specific targeting therapeutics, we will continue to study this field with our knowledge and experiences with omnidirectional bioinformatics studies and serve diverse biology research fields. ![]()
* 07/11/2024 - We provide 'Gene assessment score in pan-cancer fusion genes' information in the Download page of FusionGDB2. This file provides the individual human genes' potential impact assessment in pan-cancer fusion genes with our made scoreing methods. ![]() * Dr. Sanghyuk Lee, Professor, Department of Life Sciences, Ewha Womans University, Seoul, South Korea * Dr. Xiaobo Zhou, Professor, Department of Bioinformatics and Systems Medicine, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA * Dr. Wenshe Liu, Professor, Department of Chemistry, Texas A&M University, College Station, TX, USA * Dr. Yoon-La Choi, Associate Professor of Pathology, Sungkyunkwan University School of Medicine, Samsung Medical center, Seoul, South Korea |